Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine

Dr Sun Yung

Dr Sun Yung
Dr Sun Yung
FAS
Nexcelom Bioscience Ltd
Delegate / Speaker

Presentations at Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine

Profile of Dr Sun Yung

Sun’s scientific interest began with a Bachelor’s in Genetics, followed by a Master’s in Bioinformatics, before being seduced by the power and therapeutic potential of pluripotent stem cell biology whilst working as a lab technician. This promptly led to a PhD investigating key transcriptomic regulators that drive pluripotent stem cell differentiation, and this research continued with a post docs in Valencia, Newcastle, and Cardiff. Assay development and optimisation projects using Six Sigma and DOE methods at GE Healthcare further added to the life science tool box, before stepping out into the commercial world of scientific sales with IntelliCyt as a field application scientist and working closely with researchers in multiple scientific fields and disciplines. An acquisition by Sartorius Stedim Biotech, led to application support for ViroCyt and Essen Bioscience, before joining the Nexcelom Bioscience family.

Colleagues

Dr Kris Coupland
Nexcelom Bioscience Ltd
Dr Scott Cribbes
EMEAI Business Development Director
Nexcelom Bioscience Ltd
Mr Scott Cribbes
Director, Bus Develop Emeai
Nexcelom Bioscience Ltd
United States
Ms Paula Dickinson
EMEAi Office Operations Manager
Nexcelom Bioscience Ltd
United States
Dr Daniel Tome
Territory Sales Manager Mainland UK
Nexcelom Bioscience Ltd

Email

Please login to send a Private Message

Hosted By

Klebo (Eventflo) Conference Platform

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'